comprehensive -WSS

comprehensive

author：focus 2025-09-27 15:59:25 - browse：51776

Adobe

More than a year ago, Kaiser Permanente made waves when it said it was creating a new, sprawling entity of nonprofit hospitals and doctors with Geisinger as its first takeover — the latest example of health care companies bulking up in an already highly consolidated industry.

Nothing has happened since then, at least publicly. Geisinger’s 10 hospitals and 1,700 employed physicians are now officially part of the group, known as Risant Health. Kaiser, which is both a health insurance company and a network of providers, said it wants to add at least five to six more health systems by 2028.

Those other organizations are still a mystery. But recent financial reports show a handful of systems that have been on the same shaky trajectory as Geisinger and could find themselves in Kaiser’s crosshairs. Patients and local communities have a lot at stake if their health system gets gobbled up by Kaiser; it’s still unclear how this unique structure will alter costs or quality of care.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： The drug industry has found itself all alone in Washington

WSS

UnitedHealth quietly bought dozens of outpatient centers

The drug industry has found itself all alone in Washington

A new ‘biological computer' targets cancer while sparing healthy cells

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Extensive review finds private equity owners jack up cost of care

Sen. Paul opposes bill to ban Chinese biotechs

entertainment

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Tori Bowie and the unacceptable rates of Black maternal death

Just how do doctors, lawmakers, and the public define abortion?

Apple is now the first public company to be valued at $3 trillion

There’s a way to spot data fakery. All journals should be using it

Walensky prepares to leave CDC — and Congress — behind

Sen. Paul opposes bill to ban Chinese biotechs

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Sen. Paul opposes bill to ban Chinese biotechs

entertainment

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Amylyx ALS drug fails large clinical trial

In rare move, senator releases unverified FBI source report alleging Biden bribe

Extensive review finds private equity owners jack up cost of care

Wikipedia

Wikipedia

focus

focus